The Disease Du Jour 171: Pioneer, Generic, Compounded, and Counterfeit Animal Drugs with Stephanie Batliner
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
The Disease Du Jour 171: Pioneer, Generic, Compounded, and Counterfeit Animal Drugs with Stephanie Batliner
-
Narrated by:
-
By:
About this listen
In this episode, Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda, joined us to discuss the FDA approval process for pioneer and generic animal drugs. She also discussed veterinary devices, pharmacy compounding, counterfeit drugs, and more.
This episode of Disease Du Jour is brought to you by Bimeda.
GUESTS AND LINKS - EPISODE 171
- Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)
- Guest: Stephanie Batliner, VP of Regulatory Affairs and R&D North America for Bimeda
- Podcast Website: Disease Du Jour
- This episode of Disease Du Jour podcast is brought to you by Bimeda.
- Connect with the Host: Carly Sisson (Digital Content Manager) of EquiManagement | Email Carly (CSisson@equinenetwork.com)
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.